Clinical Trials Browser

Not yet recruiting × OTHER × Small Cell Lung Cancer Extensive Stage × Clear all

NCT06982287 2025-07-08

A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT07022301 2025-06-15

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Phase 2 Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT06851819 2025-02-28

TERE

Phase 2 Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT06825208 2025-02-13

Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial

Not yet recruiting

Small Cell Lung Cancer Extensive Stage

NCT05066945 2021-10-04

Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients

Not yet recruiting

Small Cell Lung Cancer Extensive Stage